Short description
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
Description
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to improve outcomes in HF patients. The device has been clinically validated, designated FDA Breakthrough Device and will be entering the market in 2025.
Acorai is a MedTech company with HQ in Sweden. The company has 20 FTE across 12 countries, with offices in Sweden and the UK.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Helsingborg, Skane Lan, Sweden, Europe
Founded on
August 20, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccessforu, No Way, Nopepepe, Nopepepe, Uh Ohhhh, Noaccess, Noaccessforu, Noaccess, Absolutely Noaccess, Noway Youcantaccess, Noway Youcantaccess, Noway Youcantaccess, No Way, Cannot Access
Sign in for full access
Founders
Filip Peters, Jakob Gelberg, Kasper Bourdette